1H-Pyrrole-3-Carboxylic Acid, 5-(2,4-Difluorophenyl)-4-Methoxy-, Methyl Ester

Why Does the 2,4-Difluorophenyl Substitution Drive Ergosterol Biosynthesis Inhibition?

In the multi-step assembly of triazole antifungals targeting Candida and Aspergillus species, methyl 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carboxylate functions as the late-stage eastern hemisphere fragment that donates the critical difluorinated aryl ring. Process chemistry packages developed for kilogram-scale delivery under FDA 21 CFR Part 211 enforce a strict specification of ≤0.10% for the des-fluoro impurity (monitored by UPLC with a CORTECS C18 column, 1.6 µm particles, gradient acetonitrile/0.1% formic acid). The ester is saponified to the free carboxylic acid using aqueous 2.5 M NaOH in THF/MeOH (3:1 v/v) at 40–45 °C over 18 h; any temperature excursion above 48 °C triggers decarboxylation side-reaction that bleeds into the subsequent PCl₅-mediated acyl chloride formation. In production campaigns exceeding 50 kg, batch records show that exotherm control through calibrated jacket cooling with a ΔT_jacket of ≤12 °C is essential to keep the carboxylate intermediate within a yield window of 92–95% before coupling with 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone. The crude API is resin-treated with Lewatit MP 500 MB (a macroporous strong acid cation exchanger) to scavenge residual pyrrole-related byproducts, achieving a palladium content below 5 ppm per ICH Q3D Elemental Impurities Guideline. Final product crystallization from isopropanol/water (7:3 v/v) under precise seeding conditions—0.5 wt% micronized seed crystals added at a supersaturation ratio of 1.15—delivers a polymorph designated Form I with a melting endotherm onset at 118.5 °C by DSC (capillary method, ASTM E324).

In the synthesis of voriconazole analogues where the pyrrole ring replaces the pyrimidine spacer, the methoxy substituent at position 4 is intentionally preserved to modulate cytochrome P450 metabolic stability. Data from human liver microsome assays (pooled mixed-gender donors, 1 mg/mL protein, NADPH regeneration system) demonstrate that the 4-methoxy group extends the in vitro half-life by a factor of 2.3 relative to the des-methoxy congener, while the difluorophenyl motif maintains the requisite π-stacking with the heme iron of CYP51. Production of this specific methyl ester intermediate for GMP campaigns is conducted in glass-lined reactors (Pfaudler, 200 L capacity) with N₂ blanketing, where the crude solid is isolated by centrifuge filtration (Rousselet Robatel, 0.5 m² filtration area, 2000 rpm) and dried in a conical vacuum dryer (CVD) at 40 mbar and 42 °C to an LOD ≤0.5%. The analytical certificate of analysis must list residual THF below 720 ppm and methanol below 3000 ppm to comply with ICH Q3C (R9) Class 2 solvent limits. Supply chain packaging is mandatory in double LDPE liners inside UN-certified HDPE drums with silica gel desiccant canisters.

In the current state of semi-synthetic triazole development, the pyrrole carboxylic acid methyl ester offers a synthetic advantage because it does not require orthogonal protection of the pyrrole N-H during ester hydrolysis, a problem that plagues the indole and pyrazolopyrimidine scaffolds. Process analytical technology (PAT) implementation in multi-kilo hydrolysis uses inline FTIR to track the disappearance of the ester carbonyl stretch at 1724 cm⁻¹; a termination criterion of ≤0.8% residual ester area (relative to an internal standard) triggers immediate quenching with 6 M HCl to arrest over-saponification. The resulting carboxylic acid is telescoped without isolation into amide bond formation with a primary amine fragment in the presence of HATU (1.20 eq) and DIPEA (3.0 eq) in DMF at 0–5 °C, a protocol that suppresses racemization when a chiral amino alcohol is the coupling partner. During scale-up, heat transfer limitations in the standard 200 L reactor require segmented reagent addition over 45 min to maintain a reaction temperature ≤5 °C; failure to do so results in a 6–8% enantiomer defect detectable by chiral HPLC (Chiralpak IG-3, 3 µm, n-hexane/EtOH/TFA 85/15/0.1).

When the methyl ester is retained as a prodrug latency element, the difluorophenyl-4-methoxypyrrole core is directly conjugated to a water-solubilizing group via a succinate ester linkage. This configuration demands that the commercial-grade intermediate be supplied with a heavy metal grid specification including arsenic ≤1.5 ppm, mercury ≤3.0 ppm, and lead ≤2.0 ppm. The preferred analytical technique is ICP-MS with microwave digestion in HNO₃/H₂O₂, validated per USP 〈233〉. Storage condition mapping conducted under ICH Q1A guidelines indicates that the neat solid is stable for 36 months at 25 °C/60% RH protected from light; exposure to UV-A ( 365 nm) for 14 days causes a 0.7% photolytic degradation into the debrominated analog as a key impurity, necessitating amber glass or double black PE inner bags.

In agrochemical discovery programs targeting mitochondrial Complex II inhibition in spider mites (Tetranychus urticae), the methyl ester serves as a masked carboxylic acid precursor for amide-based acaricidal candidates. The synthetic route diverges from the pharmaceutical pathway only at the point of acyl chloride formation, where thionyl chloride in toluene at reflux (110 °C) is substituted for PCl₅ to simplify workup and avoid phosphorous-containing effluent. Coupling with bulky alicyclic amines (exo-bicyclo[2.2.1]heptan-2-amine is a frequently employed motif) in a two-phase system—toluene/10 wt% aqueous K₂CO₃—at 50 °C for 6 h furnishes the amide with 87–91% isolated yield after a single recrystallization from ethyl acetate/hexane. Field trial formulations require the technical-grade active ingredient to be ≥97% pure with a single maximum unknown impurity set at ≤0.5%; this standard is aligned with FAO Specification Guidelines (Manual on development and use of FAO and WHO specifications for pesticides). The pyrrole intermediate’s residual 2,4-difluoroaniline, a potential carcinogenic contaminant, is controlled to ≤50 ppm by a validated HPLC-UV method using an amino-bonded phase column and confirmed by LC-MS/MS in MRM mode.

Commercial-scale procurement contracts for this intermediate in the agrochemical sector routinely specify a particle size distribution envelope of D₉₀ ≤ 150 µm as determined by laser diffraction (Malvern MasterSizer 3000, dry dispersion at 1 bar) to guarantee flowability through a rotary valve feeder without bridging. A lot with a D₉₀ exceeding 180 µm caused a 14% throughput reduction in a continuous amide-forming campaign running in a Corning Advanced-Flow glass reactor (G1 SiC module); subsequent root cause analysis traced the issue to slower dissolution kinetics that effectively reduced the residence time in the initial mixing zone. Consequently, incoming quality assurance now uses a sieve analysis protocol per ASTM E11-22 using 75 µm and 150 µm test sieves on a Ro-Tap RX-29 shaker for 5 min. Pre-formulated tank mixes containing the derived amide and an organosilicone surfactant (e.g., Momentive L-77 at 0.05% v/v) exhibit accelerated hydrolysis of the methyl ester when stored in high-density polyethylene containers at tropical storage conditions (54 °C/75% RH), a degradation pathway inhibited by switching to fluorinated HDPE with a EVOH barrier layer.

An Electron-Deficient Pyrrole Building Block for Type II Kinase Inhibitor Backbones

Incorporation of the 5-(2,4-difluorophenyl)-4-methoxy substitution pattern into an ATP-competitive kinase inhibitor scaffold exploits the electron-withdrawing character of the difluorinated ring to enhance hinge-binding interactions and reduce off-target hERG liability. The methyl ester functionality is deliberately preserved through six synthetic steps until the penultimate operation, where it is unmasked and converted to a primary amide under continuous-flow ammonolysis at 80 °C and 12 bar back-pressure in a Vapourtec E-Series flow system (tube reactor, 10 mL PTFE coil, residence time 15 min). Patent literature for BTK and JAK3 inhibitors cite this pyrrole core as a preferred fragment because the difluoro motif establishes favourable arene-arene interactions with the gatekeeper phenylalanine and simultaneously lowers the CLogP by approximately 0.65 log units compared to the 2,4-dichlorophenyl analogue. Process development reports highlight a stubborn impurity formed during Suzuki-Miyaura coupling when the methyl ester is present and the boronate partner is an indazole-5-pinacolborane; the impurity, identified as a dimer arising from protodeboronation followed by oxidative homocoupling, is suppressed by maintaining a rigorously oxygen-free environment (sparging with Ar for 30 min, O₂ < 0.1 ppm monitored with a PyroScience FireSting-O2 probe) and using a catalyst loading of Pd(dppf)Cl₂ at 1.5 mol% together with Cs₂CO₃ (3.0 eq) in 1,4-dioxane/water (4:1 v/v).

Residual palladium in the isolated methyl ester intermediate after the coupling step routinely falls in the 100–400 ppm range, a level incompatible with the API specification of ≤10 ppm Pd under the oral concentration limit for Elemental Class 1B metals. A combination of QuadraSil AP scavenger treatment (silica-bound mercaptopropyl, 30 wt% relative to crude) for 2 h at 60 °C followed by a n-Bu₄NHSO₄/aqueous thiosulfate wash reduces Pd to ≤8 ppm in two batch cycles. This purification sequence is executed in a Hastelloy reactor to prevent any iron contamination from stainless steel that would chelate the pyrrole nitrogen. Stability data for a representative Type II inhibitor API incorporating this fragment, packaged in Alu-Alu blister packs under nitrogen, indicate a shelf life of 24 months at 25 °C/60% RH with no change in crystalline form (confirmed by XRPD, Rigaku MiniFlex 600, Cu Kα, 2° to 40° 2θ) and total impurities maintained at ≤0.3%. Genotoxic impurity assessment follows EMA/CHMP/QWP/251344/2006 guidelines, with a focus on the methyl ester itself, which is Ames-negative in TA98, TA100, and TA1537 strains (±S9) at doses up to 5000 µg/plate.

When the 4-methoxy group is leveraged as a handle for metabolic switching, a late-stage demethylation with BBr₃ (3.0 eq) in CH₂Cl₂ at −78 °C reveals the corresponding 4-hydroxypyrrole; this intermediate is prone to oxidative dimerization under ambient air unless the vessel is carefully purged and maintained under a positive argon pressure. The resulting phenol is then O-alkylated with 2-iodopropane (1.5 eq) and K₂CO₃ (2.5 eq) in DMF at 25 °C for 16 h to install an isopropoxy group that substantially increases free fraction in human plasma protein binding studies (equilibrium dialysis, 4 h, 37 °C, 48-well HTDialysis block, 12–14 kDa MWCO membrane). For manufacturing campaigns delivering clinical-phase material, contract manufacturing organizations (CMOs) implement a Quality by Design (QbD) strategy where the design space for the alkylation step is defined by a face-centered central composite design with factors: temperature (20–40 °C), reaction time (12–20 h), and 2-iodopropane equivalents (1.3–1.8 eq). The response surface contour plots reveal that robust conditions (CpK ≥ 1.33) are achieved at 28 °C, 1.55 eq alkylating agent, with a reaction termination criterion of ≤0.15% starting phenol by HPLC.

In dyestuff and functional organic materials research, the combination of an electron-donating 4-methoxy group and an electron-withdrawing 5-(2,4-difluorophenyl) ring on a methyl pyrrole-3-carboxylate scaffold creates a push-pull chromophore with a defined intramolecular charge-transfer (ICT) absorption. The methyl ester serves as a secondary acceptor that can be transformed into a carboxylic acid or hydrazide for conjugation to a cellulose backbone. TGA/DSC analysis (Netzsch STA 449 F3 Jupiter, 10 K/min under N₂) of the pure ester shows a sharp melting endotherm at 121.0 °C and decomposition onset at 265 °C; this thermal window permits direct melt-processing into poly-L-lactic acid (PLLA) nonwoven fabrics at 170 °C for colour-tunable medical textiles. The dye loading is controlled at 0.5–2.0 wt%; above 2.2 wt%, fluorescence is quenched via aggregate formation as confirmed by a redshift from 435 nm to 468 nm in the emission maximum and a drop in quantum yield from 0.48 to 0.12 (measured using a Hamamatsu Quantaurus-QY integrating sphere, excitation at 380 nm). Dye migration tests conducted under ISO 105-C06 (A2S wash fastness, 40 °C, ECE phosphate reference detergent) on the spunbond fabric containing the saponified acid form show a staining grade of 4–5 on multifiber adjacent fabric, qualifying for use in class II medical devices per ISO 10993-5 (cytotoxicity, L929 mouse fibroblast, MTT assay).

A key processing complication arises when the methyl ester is converted in situ to the hydrazide for immobilization onto polyacrylonitrile (PAN) fibers; the reaction requires anhydrous hydrazine ( 20 eq) in methanol at 60 °C for 8 h in a sealed pressure vessel, conditions that generate a detectable level of hydrazine vapour necessitating a scrubber with 2% bleach solution. The hydrazide-functionalized fiber is then loaded with 0.8 mmol/g of the pyrrole fluorophore, achieving a covalent loading density quantified via nitrogen elemental analysis. Weatherability testing under ASTM G155 Cycle 1 (xenon arc, 0.35 W/m² at 340 nm, 63 °C black panel temperature) for 500 h reveals a colour difference ΔE*_ab of 1.8 units, substantially lower than the 4.9 units measured for an analogous coumarin dye, attributable to the photostabilizing effect of the difluorophenyl substituent.

In a niche but demanding application as a certified reference material for mass spectrometry quantification, the compound is subjected to a rigorous purification by preparative HPLC (C18, methanol/water 70/30) followed by a second recrystallization from ethyl acetate/cyclohexane (1:4). The isolated standard must pass a mass spectral isotope distribution check, reconciling the observed [M+H]⁺ cluster (theoretical m/z 298.0891) with the calculated profile within 2 ppm mass accuracy (Q-TOF, resolution ≥ 30,000 FWHM). A certificate with traceability to a U.S. Pharmacopeia or NIST standard is generated, and the material is supplied in septum-sealed vials under argon in 10 mg or 50 mg quantities. Published data for this specific configuration is limited to in-house qualification records and collaborative trial findings, but the long-term stability monitoring program demonstrates no quantifiable degradation when stored at −20 °C for 48 months.